Physician profile
Howard A Levite
NPI 1619971132
$2,365.44
in general payments reported to CMS, 2019-2025
21 companies · $348 in 2025
The $348 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $84.37 · 2021: $448 · 2022: $557 · 2023: $389 · 2024: $280 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,016.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,015.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $343.32 | 2021-2025 | Impella |
| Shockwave Medical, INC | $232.24 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $201.38 | 2021-2023 | Linq II |
| Boehringer Ingelheim Pharmaceuticals, INC. | $178.77 | 2021-2022 | |
| Boston Scientific Corporation | $167.32 | 2019-2024 | Avvigo Guidance System |
| Esperion Therapeutics, INC. | $125.00 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $120.29 | 2023 | Camzyos |
| Janssen Pharmaceuticals, INC | $111.56 | 2023 | Xarelto |
| Medtronic Vascular, INC. | $110.64 | 2019 | |
| Novo Nordisk INC | $107.23 | 2021-2025 | Ozempic |
| Pfizer INC. | $99.99 | 2022 | |
| Inari Medical, INC. | $99.93 | 2022 | |
| Abbott Laboratories | $98.14 | 2019-2025 | Navitor, Pressurewire |
| Biosense Webster, INC. | $82.06 | 2023-2024 | Carto 3 |
| Novartis Pharmaceuticals Corporation | $78.28 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $51.67 | 2020-2022 | |
| Angiodynamics, INC. | $44.96 | 2024-2025 | Alphavac |
| Cardiovascular Systems INC. | $39.93 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $36.23 | 2020-2021 | |
| Cardiva Medical, INC. | $20.50 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| W. L. Gore & Associates, INC. | $16.00 | 2023 | Gore Cardioform Septal Occluder |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Levite listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.